Potential of regenerative medicine explored

NEW YORK, June 14 Clinical and basic science research findings of more than a dozen studies are being presented by researchers from the University of Pittsburghs McGowan Institute for Regenerative Medicine at the 48th Annual Meeting of the American Society for Artificial Internal Organs. The scientific sessions are June 13-15 at the New York Hilton Hotel. Highlights of the findings include:

  • Filtering antibodies from blood may decrease the risk of organ rejection, William Federspiel, Ph.D., associate professor of chemical engineering and surgery and bioengineering at the University of Pittsburgh School of Medicine, graduate student Mariah Hout and their colleagues report. Dr. Federspiel, who is also director of the artificial lung lab at Pitts McGowan Institute for Regenerative Medicine, said that experiments using a hollow fiber material similar to that contained in a typical dialysis filter showed that between 40 percent and 60 percent of targeted rejection antibodies were removed when the fibers were coated with specific antigens. These "specific antibody filters" are showing promise in initial lab tests and may eliminate the need for time-intensive plasma replacement therapy in immunologically sensitive patients prior to transplantation. Ms. Hout will be presenting this work Friday, June 14.

  • An injected solution of blood-soluble drag-reducing polymers (DRPs) improved survival rates in a low-oxygen environment, according to work done in animal models by Marina Kameneva, Ph.D., research associate professor of surgery in the McGowan Institute for Regenerative Medicine at the University of Pittsburgh, and her colleagues. Dr. Kamenevas research group injected a solution of such polymers at minute concentrations into the tail veins of experimental rats, which were then subjected to atmospheric pressure corresponding to an altitude of more than 25,000 feet. Control animals that had been injected with the same volume of saline solu

Contact: Michele D. Baum
University of Pittsburgh Medical Center

Page: 1 2 3

Related biology news :

1. Potential for enhanced sequestration of carbon in soils supports evaluations
2. Potential blood test for colon cancer risk
3. Potential new treatment for Gaucher disease developed by scientists at Scripps Research Institute
4. Potential cause of arthritis discovered
5. Potential therapy reported for children, adults with end-stage liver disease
6. Potential allergy vaccine boosts hope for sufferers
7. Potential of tailoring drugs to genetic makeup confirmed--but challenges remain
8. Potential new anthrax therapy discovered
9. Potential gene therapy carriers created that mimic viruses, without the risk
10. New Class Of Synthetic Capsules That Mimic Biological Cells Has Wide Array Of Potential Uses
11. Role Of Protein Linked To Colon Cancer Identified, Offering Potential Target For Therapy

Post Your Comments:

(Date:8/7/2020)... ... 06, 2020 , ... Nine middle school teachers from eight ... a unique professional development program that provides advanced STEM (science, technology, engineering and ... nationwide. , Created in partnership between the National Stem Cell Foundation and The ...
(Date:7/31/2020)... ... July 30, 2020 , ... Justin ... portfolio with a near term focus on Type 2 diabetes and associated comorbidities. ... across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin will lead ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • ... comparability study, but what is the most effective way to complete one? Will ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... ... radar transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and ... can drive one or two switches in a push-pull configuration; yielding fast fall ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
(Date:7/22/2020)... ... 2020 , ... Join experts from Reed Tech , Gary Saner, Sr. ... one hour live webinar on Thursday, August 13, 2020 at 11am EDT ... medical devices. Specifically, for medical devices, the NMPA has departments dealing with medical device ...
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign , ... and prevention of high-burden diseases, and Centric Consulting, a business and technology consulting ... utilize existing data in order to identify and prioritize patients for care. , ...
Breaking Biology Technology:
Cached News: